La Narcolepsie-Cataplexie aujourd'hui

DEPIERREUX, Frédérique; FANIELLE, Julien; Lecomte, Marianne; HANS, Grégory; MAQUET, Pierre; POIRRIER, Robert

Download

Article (Scientific journals)

La Narcolepsie-Cataplexie aujourd'hui

DEPIERREUX, Frédérique; FANIELLE, Julien; Lecomte, Marianne et al.

2014 • In Revue Médicale de Liège, 69 (2), p. 72-81

Peer reviewed

Permalink
https://hdl.handle.net/2268/160652

PubMed
24683827

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

La narcolepsie aujourd'hui.pdf

Publisher postprint (868.78 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Narcolepsy-cataplexy; Hypocretin; Orexin; Sodium-Oxybate; Diagnosis; Treatment; Diagnostic; Traitement; Narcolepsie-cataplexie; Hypocrétine; Orexine

Abstract :

[en] Diagnostic criteria and pathophysiology of narcolepsy-
cataplexy have evolved considerably over the last 10 years.
The main cause, already mentioned in a previous paper, in the
Revue Médicale de Liège, in 2002, is based, in human beings,
on a destruction of specific cells located in the lateral and
posterior part of the hypothalamus (the perifornical nuclei,
containing some 70,000 neurons), producing peptides which
stimulate the central nervous system; they are called hypocretins
or orexins. The role of autoimmunity in their disappearance
becomes more evident. The treatment is simplified but
remains symptomatic. It is mainly based on Sodium Oxybate
or Gamma-Hydroxybutyrate, syrup, prescribed for the night.
The authors report on their own experience in this regard and
on future therapeutics more targeted towards the cause of the
disease.

Research Center/Unit :

CHU de Liège, service de neurologie

Disciplines :

Neurology

Author, co-author :

DEPIERREUX, Frédérique ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman

FANIELLE, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman

Lecomte, Marianne ; Université de Liège > Département des sciences cliniques > Département des sciences cliniques

HANS, Grégory ; Centre Hospitalier Universitaire de Liège - CHU > Anesthésie et réanimation

MAQUET, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman

POIRRIER, Robert ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman

Language :

French

Title :

La Narcolepsie-Cataplexie aujourd'hui

Alternative titles :

[en] Narcolepsy-Cataplexy Today

Publication date :

2014

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

72-81

Peer reviewed :

Peer reviewed

Available on ORBi :

since 06 January 2014

Statistics

Number of views

732 (70 by ULiège)

Number of downloads

4460 (45 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Lhermitte J.-Le syndrome narcoleptique In: Lhermitte J, editor. Le sommeil. Paris. Librairie Armand Colin, 1931, 153-183.
Dorris L, Zuberi SM, Scott N, et al.-Psychosocial and intellectual functioning in childhood narcolepsy. Dev Neurorehabil, 2008, 11, 187-194.
Ha KS, Yoo HK, Lyoo IK, et al.-Computerized assessment of cognitive impairment in narcoleptic patients. Acta Neurol Scand, 2007, 116, 312-316.
Daniels E, King MA, Smith IE, et al.-Health-related quality of life in narcolepsy. J Sleep Res, 2001, 10, 75-81.
Dodel R, Peter H, Walbert T, et al.-The socioeconomic impact of narcolepsy. Sleep, 2004, 27, 1123-1128.
Jennum P, Knudsen S, Kjellberg J.-The economic consequences of narcolepsy. J Clin Sleep Med, 2009, 5, 240-245.
Ingravallo F, Schenck CH, Plazzi G.-Injurious REM sleep behaviour disorder in narcolepsy with cataplexy contributing to criminal proceedings and divorce. Sleep Med, 2010, 11, 950-952.
Dauvilliers Y, Montplaisir J, Molinari N, et al.-Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology, 2001, 57, 2029-2033.
American Academy of Sleep Medicine.-Hypersomnias of central origin not due to a circadian rhythm sleep disorder, sleep related breathing disorder, or other cause of disturbed nocturnal sleep. Narcolepsy with cataplexy. The International Classification of sleep disorders, 2nd edition. Diagnostic and coding manual. Westchester, Illinoi. Am Acad Sleep Med, 2005, 81-86.
Mignot E.-Genetic and familial aspects of narcolepsy. Neurology, 1998, 50, S16-S22.
de Lecea L, Kilduff TS, Peyron C, et al.-The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA, 1998, 95, 322-327.
Sakurai T, Amemiya A, Ishii M, et al.-Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998, 92, 573-585.
Tsujino N, Sakurai T.-Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci, 2013, 7
Lin L, Faraco J, Li R, et al.-The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999, 98, 365-376.
Chemelli RM, Willie JT, Sinton CM, et al.-Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999, 98, 437-451.
Ludvikova E, Nishino S, Sakai N.-Familial narcolepsy in the Lipizzaner horse: a report of three fillies born to the same sire. Vet, 2012, 32, 99-102.
Peyron C, Faraco J, Rogers W, et al.-A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med, 2000, 6, 991-997.
Nishino S, Ripley B, Overeem S, et al.-Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000, 355, 39-40.
Peyron C, Faraco J, Rogers W, et al.-A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med, 2000, 6, 991-997.
Thannickal TC, Moore RY, Nienhuis R, et al.-Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27, 469-474.
Mignot E, Lammers GJ, Ripley B, et al.-The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol, 2002, 59, 1553-1562.
Krahn LE, Pankratz VS, Oliver L, et al.-Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep, 2002, 25, 733-736.
Ripley B, Overeem S, Fujiki N, et al.-CSF hypocretin/ orexin levels in narcolepsy and other neurological conditions. Neurology, 2001, 57, 2253-2258.
Mieda M, Tsujino N, Sakurai T.-Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol, 2013, 4
Tsujino N, Sakurai T.-Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci, 2013, 7
Oishi Y, Williams RH, Agostinelli L, et al.-Role of the medial prefrontal cortex in cataplexy. J Neurosci, 2013, 33, 9743-9751.
Mignot E, Hayduk R, Black J, et al.-HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep, 1997, 20, 1012-1020.
Mignot E, Lin L, Rogers W, et al.-Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet, 2001, 68, 686-699.
Mignot E, Lin X, Arrigoni J, et al.-DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep, 1994, 17, S60-S67.
Mignot E, Kimura A, Lattermann A, et al.-Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens, 1997, 49, 329-341.
Thannickal TC, Siegel JM, Nienhuis R, et al.-Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol, 2003, 13, 340-351.
Feneberg E, Steinacker P, Lehnert S, et al.-Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy. Sleep Med, 2013, 14, 692-694.
Deloumeau A, Bayard S, Coquerel Q, et al.-Increased immune complexes of hypocretin autoantibodies in narcolepsy. PLoS One, 2010, 5, e13320.
Kawashima M, Lin L, Tanaka S, et al.-Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep, 2010, 33, 869-874.
Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al.-Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest, 2010, 120, 713-719.
Hallmayer J, Faraco J, Lin L, et al.-Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet, 2009, 41, 708-711.
Kornum BR, Kawashima M, Faraco J, et al.-Common variants in P2RY11 are associated with narcolepsy. Nat Genet, 2011, 43, 66-71.
Han F, Lin L, Warby SC, et al.-Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol, 2011, 70, 410-417.
Han F, Lin L, Warby SC, et al.-Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol, 2011, 70, 410-417.
Lakemedelsverket.-Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations-results of a case inventory study by the MPA in Sweden during 2009-2010. MPA Report, 2011, 1, 1-20.
Szakacs A, Darin N, Hallbook T.-Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology, 2013, 80, 1315-1321.
Wijnans L, Lecomte C, de Vries C, et al.-The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine, 2013, 31, 1246-1254.
Miller E, Andrews N, Stellitano L, et al.-Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ, 2013, 346.
Savvidou A, Knudsen S, Olsson-Engman M, et al.-Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. Sleep, 2013, 36, 147-148.
Peyron C, Faraco J, Rogers W, et al.-A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med, 2000, 6, 991-997.
Khor SS, Miyagawa T, Toyoda H, et al.-Genomewide association study of HLA-DQB1*06:02 negative essential hypersomnia. Peer J, 2013, 1, e66.
Inocente CO, Lavault S, Lecendreux M, et al.-Impact of obesity in children with narcolepsy. CNS Neurosci Ther, 2013, 19, 521-528.
Jennum P, Ibsen R, Knudsen S, et al.-Comorbidity and mortality of narcolepsy: a controlled retro-and prospective national study. Sleep, 2013, 36, 835-840.
Poli F, Pizza F, Mignot E, Ferri R, et al.-High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep, 2013, 36, 175-181.
John J, Thannickal TC, McGregor R, et al.-Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann Neurol, 2013, 10, ahead of print.
Bassetti CL, Baumann CR, Dauvilliers Y, et al.-Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res, 2010, 19, 620-623.
Grimaldi D, Calandra-Buonaura G, Provini F, et al.-Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep, 2012, 35, 519-528.
Dauvilliers Y, Pennestri MH, Whittom S, et al.-Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy. Sleep, 2011, 34, 219-223.
Sansa G, Iranzo A, Santamaria J.-Obstructive sleep apnea in narcolepsy. Sleep Med, 2010, 11, 93-95.
Pataka AD, Frangulyan RR, Mackay TW, et al.-Narcolepsy and sleep-disordered breathing. Eur J Neurol, 2012, 19, 696-702.
Han F, Mignot E, Wei YC, et al.-Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1*0602 status. Eur Respir J, 2010, 36, 577-583.
Broughton R, Mamelak M.-The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci, 1979, 6, 1-6.
Thorpy M.-Orally administered sodium oxybate for the treatment of narcolepsy. Curr Neurol Neurosci Rep, 2004, 4, 155-156.
Robinson DM, Keating GM.-Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs, 2007, 21, 337-354.
Mignot EJ.-A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics, 2012, 9, 739-752.
Bastuji H, Jouvet M.-Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry, 1988, 12, 695-700.
Mignot EJ.-A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics, 2012, 9, 739-752.
Borgen LA, Okerholm RA, Lai A, Scharf MB.-The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol, 2004, 44, 253-257.
Knudsen S, Mikkelsen JD, Bang B, et al.-Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy. Neuropediatrics, 2010, 41, 217-222.
Deflandre E, Roelants F, Cambron L, Poirrier R.-La Narcolepsie- Cataplexie. Rev Med Liege, 2002, 57, 519-527.